Abstract
COVID-19 has negative repercussions on psychological aspects of the individual. Provision of personalized assistance to each individual is a task which cannot be fulfilled by the health system. In this context religion remains to be an effective tool. A qualitative study was conducted to find the spiritual practices and coping mechanisms of COVID-19 infected people(N=15, mean age =46.3 years) in Kurunegala district. Data collection was conducted using in-depth interviews and thematic analysis was conducted. The main themes found were Fatalism and perceived risk of COVID 19, Adherence to health care guidelines despite fatalistic beliefs, Religious coping in COVID 19, Spiritual practices for coping with stress/ distress and Fatalism as a positive force for self-care. It is imperative to manage the pandemic with the assistance of religion and spiritual practices.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical review committee, Provincial Health Services, North Western Province, Sri Lanka
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
rasu.ranasinghe{at}gmail.com
ranasinghe.li2017{at}pgim.cmb.ac.lk
pathiraja75{at}gmail.com
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.